Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8

NCT02882217 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: XC8 (histamine glutarimide)
DRUG: Placebo

Sponsor

EURRUS Biotech GmbH